RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Marcos Ramos-Benitez to Prognosis

This is a "connection" page, showing publications Marcos Ramos-Benitez has written about Prognosis.
Connection Strength

0.238
  1. Ramos-Benitez MJ, Miao R, Rivera-Torres AP, Lacourt-Ventura M, Malavez-Cajigas SJ, Tian X, Teague HL, De Jesus-Rojas W, Reger R, Suffredini AF, King C, Nathan SD, Childs RW, Strich JR. Surfactant Protein D and Club Cell Secretory Protein as Biomarkers of Disease Severity and Fostamatinib Efficacy in Severe COVID-19. Crit Care Explor. 2025 Apr 01; 7(4):e1252.
    View in: PubMed
    Score: 0.189
  2. Arif M, Basu A, Zuo BLG, Zuo MXG, O'Brien KJ, Pommerolle L, Caro-Rivera LM, De Jesus-Rojas W, Ramos-Benitez MJ, Behan M, Introne WJ, Frost G, Moaddel R, Gahl WA, Malicdan MCV, Gochuico BR, Cinar R. Choline and CCL22 Are Prognostic Blood Biomarkers for Hermansky-Pudlak Syndrome Pulmonary Fibrosis. Am J Respir Cell Mol Biol. 2026 Jan 01; 74(1):80-93.
    View in: PubMed
    Score: 0.050
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support